Expired Tender Czech Republic ICB TOT Ref. 114320659

Antiviral for Systemic Use - Hbv - Vemlidy I. Tender - 114320659

Tender notice from Czech Republic, published on 06 Feb 2025.

Exeutive Summary

The INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE has issued a Tender notice for the procurement of a Antiviral for Systemic Use - Hbv - Vemlidy I. in the Czech Republic. This Tender notice was published on 06 Feb 2025 and is scheduled to close on 11 Mar 2025, with an estimated Tender value of CZK 11166000. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 114320659, while the tender notice number is 82636-2025 and Register on the platform.

Key facts

Summary
Antiviral for Systemic Use - Hbv - Vemlidy I.
TOT Ref. No.
114320659
Document Ref. No.
82636-2025
Country
Czech Republic
Notice type
Tender
Competition
ICB
Publication date
06 Feb 2025
Bid deadline
11 Mar 2025
EMD
Refer Document
Tender value
CZK 11166000
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

The subject of the public contract is the supply of a medicinal product containing the active substance tenofovir-alafenamide (ATC J05AF13) for the treatment of patients in approved indications according to the SPC valid on the date of bids. The subject of this VZ is intended for native patients and switch patients so far treated with reference medicinal
Document Type: Contract Notice

Reference Number: PZ-2025-0000094

Contract Type: supplies

Estimated Value: 11166000 - CZK

Authority Type: body-pl-cga

Doc Title: Antivirotika pro systemove použiti HBV - Vemlidy I.

Dispatch Date: 2025-02-05

Publish Date: 2025-02-06

Submission Date: 2025-03-11

Documents

Tender Notice
Login to view

Corresponding contract award notice

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Medicinal Products Containing Gilteritinib - Combined Purchase 2026 Czech Republic 152592611 20 Nov 2026
Combination of Coagulation Factors Ix, Ii, Vii and X Atc Group B02bd01 Czech Republic 152592586 21 Dec 2026
Monitors of Vital Functions 3 Pcs Czech Republic 152592217 18 Dec 2026
Fnmh - Custom Sets for Orthopedic Operations Czech Republic 152586995 05 Jan 2027
Supply of battery-powered surgical drilling and sawing machines with accessories for Central Operating Rooms ** Czech Republic 152586907 30 Nov 2026

Czech Republic Public Procurement Intelligence

Frequently asked questions

The bid deadline for Antiviral for Systemic Use - Hbv - Vemlidy I. was 11 Mar 2025. Bidding is closed.

This tender has been issued by INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE in Czech Republic.

The estimated tender value is CZK 11166000. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33651400 - Antivirals for systemic use.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 114320659. The purchaser document reference is 82636-2025.

See the Similar Tenders section on this page or browse other tenders from Czech Republic.

This tender falls under Materials and Products, Technology and Equipment in Czech Republic. Suppliers in these sectors can track similar Czech Republic tenders using CPV-based alerts.